Adipotide

A prohibitin-targeting peptide that killed fat tissue blood vessels in primate studies, never taken through human obesity trials.

What research shows

Adipotide is a prohibitin-targeting peptidomimetic that produced weight loss in animal studies, including primates. It never progressed to human obesity trials, and kidney toxicity concerns are part of why. No human safety or dosing data was verified in the literature searched.

Evidence strength

Highest evidence grade among the graded claims: C. Grades reflect study strength, not benefit.

Safety context

See the safety section. Absence of a flag is not evidence of safety.

No endorsement

A grade reflects evidence strength, not a recommendation to use this compound; a strong grade can attach to a harmful effect.